Diltiazem Hydrochloride
NDC 70436-197, Diltiazem Hydrochloride, tablet, extended release, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-197
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216439
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-197 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DILTIAZEM HYDROCHLORIDE240 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-197-04 | 70436019704 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-197-04) |
| 70436-197-06 | 70436019706 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-197-06) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f7137458-0db3-7ecd-e053-6394a90a5f95NADAC price for package 70436019704
GET /v1/drugs/nadac/70436019704
Use it
Look up 70436-197 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-197 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-197. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.